EARLY ALZHEIMER'S DISEASE
Clinical trials for EARLY ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new EARLY ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for EARLY ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a new pill slow Alzheimer's? major trial underway
Disease control OngoingThis study tests an experimental drug called CT1812 in people with early Alzheimer's disease. About 540 participants will receive either the drug or a placebo for 18 months to see if it can slow down memory and thinking problems. The goal is to find a safe treatment that helps co…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Cognition Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New hope for early Alzheimer's: Long-Term drug trial targets High-Risk gene carriers
Disease control OngoingThis study looks at the long-term safety and effects of a drug called ALZ-801 in people with early Alzheimer's disease who have a specific gene (APOE4/4). About 163 participants who completed a previous study will continue taking ALZ-801 for up to 2 more years. Researchers will t…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Alzheon Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Promising Alzheimer's drug moves to final testing phase
Disease control OngoingThis study tests a drug called lecanemab (BAN2401) in 1906 people with early Alzheimer's disease. The goal is to see if it slows down memory and thinking decline compared to a placebo over 18 months. Participants who complete the main study can join an extension to continue treat…
Matched conditions: EARLY ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated May 20, 2026 11:53 UTC